Skip to main content
Clinical Trials/IRCT20120918010876N3
IRCT20120918010876N3
Completed
Phase 2

Assessment of efficacy of antenatal betamethasone on neonatal respiratory outcome of late preterm delivery (34-37 weeks) in singleton pregnancies

Shahid Beheshti University of Medical Sciences- Mahdieh Hospital0 sites200 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Respiratory distress syndrome of newborn.
Sponsor
Shahid Beheshti University of Medical Sciences- Mahdieh Hospital
Enrollment
200
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Shahid Beheshti University of Medical Sciences- Mahdieh Hospital

Eligibility Criteria

Inclusion Criteria

  • Singleton pregnancy
  • Gestational age from 34 weeks and 0 days to 36 weeks and 6 days
  • High probability of preterm labor (in weeks 37\-34\) due to premature rupture of membranes
  • Preterm labor with intact membranes
  • preterm labor with any indication (including previous cesarean section, intrauterine growth retardation (IUGR), Oligohydramnios, pre\-eclampsia, etc.)

Exclusion Criteria

  • No exact gestational age (unknown firt day of last menstrual period (LMP) or no ultrasound dating)
  • Cervix dilatation of 4 cm or more
  • Planned delivery after 36 weeks and 6 days
  • Known congenital malformations
  • Received corticosteroids before week 34 or for other indications
  • Fetal death
  • Major fetal anomaly
  • Non\-viable fetus
  • Gestational diabetes
  • Diabetes before pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials